| Trial ID: | L1020 |
| Source ID: | NCT04925011
|
| Associated Drug: |
Roxadustat
|
| Title: |
Investigating the Efficacy and Safety of Roxadustat (FG-4592) for Treatment of Anemia in Pediatric Patients With CKD
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Anemia Associated With Chronic Kidney Disease
|
| Interventions: |
DRUG: Roxadustat
|
| Outcome Measures: |
Primary: Proportion of patients with mean Hb ≥ 11.0 g/dL, After the use of roxadustat, the proportion of patients with mean Hb ≥ 11.0 g/dL, weeks 16-24 | Secondary: Mean change in Hb, weeks 16-24
|
| Sponsor/Collaborators: |
Sponsor: Mao Jianhua
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT
|
| Phases: |
PHASE3
|
| Enrollment: |
30
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2021-09-01
|
| Completion Date: |
2022-12-30
|
| Results First Posted: |
|
| Last Update Posted: |
2021-08-09
|
| Locations: |
Children's Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
|
| URL: |
https://clinicaltrials.gov/show/NCT04925011
|
